Delivery Order SPE2DR25D6037-SPE2DR26FXK4P
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,088.77. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a non-set-aside award issued through competitive procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count) with a ceiling value of $1,095.15. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $1,122.42. This competitively awarded, firm fixed-price delivery order is expected to be completed by October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation and represents a child delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count containers) with a ceiling value of $4,218.80. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) valued at $1,603.56. This firm fixed-price delivery order is scheduled for completion by September 22, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,020.12 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The pharmaceutical products will be delivered to the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $2,139.28. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025. The award utilized no set-aside designation and was competitively awarded through an open procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,291.32 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- SPE2DR25D6037Indefinite Delivery Contract
- SPE2DR25D6037-SPE2DR26FXK4PDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $5,523.81. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical support vehicle extending through December 2026. As a prime contractor under this global pharmaceutical prime vendor contract, AmerisourceBergen supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and the Defense Health Agency. The current award reflects the company's ongoing role as a critical pharmaceutical distributor within the federal medical supply chain, fulfilling specific medication requests through structured delivery orders under the master contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 10/28/25 |